Comparison of EQ-5D and SF-6D utilities in mental health patients

Health Economics
L M LamersL Hakkaart

Abstract

Various preference-based measures of health are available for use as an outcome measure in cost-utility analysis. The aim of this study is to compare two such measures EQ-5D and SF-6D in mental health patients. Baseline data from a Dutch multi-centre randomised trial of 616 patients with mood and/or anxiety disorders were used. Mean and median EQ-5D and SF-6D utilities were compared, both in the total sample and between severity subgroups based on quartiles of SCL-90 scores. Utilities were expected to decline with increased severity. Both EQ-5D and SF-6D utilities differed significantly between patients of adjacent severity groups. Mean utilities increased from 0.51 at baseline to 0.68 at 1.5 years follow-up for EQ-5D and from 0.58 to 0.70 for SF-6D. For all severity subgroups, the mean change in EQ-5D utilities as well as in SF-6D utilities was statistically significant. Standardised response means were higher for SF-6D utilities. We concluded that both EQ-5D and SF-6D discriminated between severity subgroups and captured improvements in health over time. However, the use of EQ-5D resulted in larger health gains and consequent lower cost-utility ratios, especially for the subgroup with the highest severity of mental health pro...Continue Reading

References

Jan 1, 1982·Medical Decision Making : an International Journal of the Society for Medical Decision Making·H Llewellyn-ThomasN F Boyd
Sep 1, 1995·Medical Care·M P Rutten-van MölkenS van der Linden
Jan 1, 1994·Medical Decision Making : an International Journal of the Society for Medical Decision Making·D L PatrickR A Pearlman
Mar 1, 1996·Health Economics·P DolanA Williams
Nov 21, 1997·Medical Care·P Dolan
May 8, 1995·PharmacoEconomics·D FeenyG W Torrance
Jun 6, 1996·Health Policy·R Brooks
Oct 6, 2000·Journal of Personality Disorders·S KoolF de Jonghe
Apr 10, 2002·Journal of Health Economics·John BrazierMark Deverill
Dec 16, 2003·Health Economics·Louise Longworth, Stirling Bryan
Sep 14, 2004·Health Economics·John BrazierJan Busschbach
Mar 26, 2005·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·A Simon PickardDavid H Feeny

❮ Previous
Next ❯

Citations

Jul 3, 2007·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Garry R BartonKenneth R Muir
Mar 11, 2008·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Richard GrieveJohn Cairns
May 18, 2010·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Nick KontodimopoulosDimitris Niakas
Dec 7, 2010·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Nick KontodimopoulosDimitris Niakas
Jul 26, 2011·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Yemi OluboyedeChris McCabe
Jun 9, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Lene Lunde
Aug 9, 2008·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Pedro L FerreiraLuis N Pereira
Dec 4, 2008·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Nick KontodimopoulosDimitris Niakas
Dec 24, 2008·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·A SzendeK Svensson
Sep 4, 2009·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Uwe KonerdingThomas Kohlmann
Apr 1, 2010·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Oriol CunilleraMontse Ferrer
Sep 14, 2012·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Eric JutkowitzLaura N Gitlin
Apr 9, 2013·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Carlos K H WongCindy L K Lam
Dec 29, 2012·Health and Quality of Life Outcomes·Hendramoorthy MaheswaranSarah Stewart-Brown
Dec 25, 2013·Health and Quality of Life Outcomes·Michael SonntagHans-Helmut König
May 11, 2013·Health and Quality of Life Outcomes·Nicholas TurnerSandra Hollinghurst
May 24, 2014·The British Journal of Psychiatry : the Journal of Mental Science·Brendan MulhernJohn Brazier
Aug 4, 2009·The British Journal of Psychiatry : the Journal of Mental Science·Garry R BartonDavid Fowler
Apr 2, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Anna FernándezUNKNOWN DASMAP investigators
Nov 3, 2010·The British Journal of Psychiatry : the Journal of Mental Science·John Brazier
May 4, 2011·Journal of Communication Disorders·Caroline KoedootElly Stolk
Dec 20, 2008·European Psychiatry : the Journal of the Association of European Psychiatrists·A D I van AsseltJ L Severens
Nov 5, 2015·Health and Quality of Life Outcomes·Michael SonntagAlexander Konnopka
Oct 9, 2009·Journal of Evaluation in Clinical Practice·David K Whynes, UNKNOWN TOMBOLA Group
Sep 26, 2007·Health Economics·Garry R BartonKenneth R Muir
Oct 7, 2011·Health Economics·José María Abellán PerpiñánIldefonso Méndez
Jan 16, 2014·Health and Quality of Life Outcomes·Jennifer RobertsJohn Brazier
Aug 16, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Sylvia A H GerhardsSilvia M A A Evers
Mar 17, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Lara N FerreiraDonna Rowen
Oct 25, 2014·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·T A KantersL Hakkaart

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.